NSEOutcome of Board Meeting5h ago · 25 Sept 2026, 01:29 pm
Outcome of Board Meeting
Molbio Diagnostics Limited · MOLBIO
✦ AI Summary
Molbio Diagnostics Limited has informed the Exchange regarding the re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27.
Attachments (1)
📄pdf
Download →
MOLBIO_25092026132851_Intimation_Cost_auditor_Signed.pdf
View document text
Date: September 25, 2026
BSE Limited (BSE’) National Stock Exchange of India Ltd
Listing Department Exchange Plaza,
Corporate Relationship Department B a n d r a - Kurla Complex,
Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai 400 051
2nd Floor, Dalal Street, Symbol: MOLBIO
Mumbai – 400 001
BSE Script Code: 544866
Subject: Intimation of re-appointment of Cost Auditor of the Company pursuant
to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015.
Dear Sir/Ma’am,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we wish to inform you that the Board of Directors, at their meeting
held on today, September 25, 2026, has inter-alia considered and approved the following:
1. Re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants (Firm Reg. No:
000296), a Peer-reviewed firm as the Cost Auditors of the Company to conduct audit of
the cost accounts for the Financial Year 2026-27.
The disclosure as required under Regulation 30 of SEBI (Listing Obligation and
Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as amended
from time to time are enclosed here as “Annexure-A”
The Board Meeting commenced at 11.26 A.M and concluded at 11.35 A.M.
The above intimation is also available on the Company’s website at
www.molbiodiagnostics.com in compliance with Regulation 46 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015.
We request you to kindly take the same on your record.
Thanking You.
Yours Faithfully,
For Molbio Diagnostics Limited
Darshan Raghunath Karekar
Company Secretary & Compliance Officer
M.No: F13569
Place: Verna-Goa
Annexure – A
Disclosure as required pursuant to Regulation 30 of the SEBI (Listing Obligation
and Disclosure Requirements) Regulations, 2015 read with the SEBI Master
Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30,
2026:
Sr. Particulars Details
1 Reason for change viz Re-appointment of M/s. Kamalakara & Co,
appointment, resignation; (FRN:000296), Cost accountant, as the cost
removal-death-or-otherwise: auditors of the Company for the financial year
2026-27.
2 Date of Date of Re-appointment: September 25, 2026.
appointment/cessation—(as— Term of Re-appointment: For the financial year
applicable) & term of 2026-27.
appointment
3 Brief profile (in case of M/s. K.S. Kamalakara & Co. is a prominent and
appointment/ re-appointment). professionally managed firm of Cost Accountants
(Firm Registration No. 000296) based in
Bengaluru, India.
The firm specializes in GST, Cost Accounting,
Financial Accounting, Import-Export Policy,
Customs, Export Benefit Claims, FEMA
compliances, litigation support, and preparation
of project reports for financing and other business
requirements.
The firm is led by its founding partner, CMA K. S.
Kamalakara (M.Com., FCMA), a Fellow Cost
Accountant with over two decades of experience
and expertise in cost records, cost audits, indirect
taxation, and corporate litigation matters.
4 Disclosure of relationships NA
between directors (in
case of appointment of a
director)